Relmada Therapeutics
Price & Volume
Stats
See moreOpen | $6.88 |
Previous Close | $6.98 |
Day Range | $6.88-$7.08 |
52W Range | $0.55-$8 |
Market Cap | $702.3M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.09 |
News
See moreYahoo Finance • 2 months ago
After-Hours Earnings Report for May 12, 2026 : FNV, NXT, OKLO, KRMN, REZI, ATRO, CAPR, AIP, EVLV, KURA, RLMD, GAIN
Yahoo Finance • 2 months ago
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
Yahoo Finance • 4 months ago
Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026
Yahoo Finance • 7 months ago
Relmada Therapeutics Announces Presentation of NDV-01 Phase 2 Data at the Society for Urologic Oncology
About
CEO | Dr. Sergio Traversa M.B.A., Pharm.D. |
Address | 2222 Ponce de Leon Blvd., Coral Gables, FL, United States, 33134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |